A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer☆
To access this article, please choose from the options below
☆ Presented as preliminary data at the 44th American Society of Clinical Oncology meeting held in Chicago, IL, May 30th–June 3rd, 2008.
PII: S0169-5002(09)00122-6
doi:10.1016/j.lungcan.2009.02.024
© 2009 Elsevier Ireland Ltd. All rights reserved.
